aspirin has been researched along with Deficiency of Glucose-6-Phosphate Dehydrogenase in 38 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of aspirin, as part of a dual antiplatelet therapy regimen, is an established standard following coronary stenting in patients suffering from acute coronary syndrome (ACS)." | 8.95 | Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention. ( Al Hout, AR; Feghaly, J; Mercieca Balbi, M, 2017) |
| "Patients with ischemic stroke receiving aspirin (100 mg/day) for three months were recruited for a multicenter, prospective, cohort study." | 8.02 | Safety and efficacy of low-dose aspirin in ischemic stroke patients with different G6PD conditions. ( Chen, Y; Deng, W; Huang, W; Jiang, H; Li, J; Liang, Z; Liu, Q; Ou, Z; Ouyang, F; Wu, Z; Xing, S; Zeng, J; Zhang, Y, 2021) |
| "In total, 279 patients (40 G6PD-deficient and 239 G6PD-normal) with acute ischemic stroke treated with aspirin 100 mg/day from a cohort study were examined." | 8.02 | Association between aspirin-induced hemoglobin decline and outcome after acute ischemic stroke in G6PD-deficient patients. ( Chen, Y; Deng, W; Huang, W; Li, J; Liang, Z; Ou, Z; Ouyang, F; Xing, S; Yu, J; Zeng, J; Zhang, Y, 2021) |
| "Aspirin is an important drug in acute coronary syndromes (ACS) and percutaneous coronary interventions (PCI)." | 7.81 | Antiplatelet and invasive treatment in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency and acute coronary syndrome. The safety of aspirin. ( Kafkas, NV; Liakos, CI; Mouzarou, AG, 2015) |
| "The use of aspirin, as part of a dual antiplatelet therapy regimen, is an established standard following coronary stenting in patients suffering from acute coronary syndrome (ACS)." | 4.95 | Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention. ( Al Hout, AR; Feghaly, J; Mercieca Balbi, M, 2017) |
| "Patients with ischemic stroke receiving aspirin (100 mg/day) for three months were recruited for a multicenter, prospective, cohort study." | 4.02 | Safety and efficacy of low-dose aspirin in ischemic stroke patients with different G6PD conditions. ( Chen, Y; Deng, W; Huang, W; Jiang, H; Li, J; Liang, Z; Liu, Q; Ou, Z; Ouyang, F; Wu, Z; Xing, S; Zeng, J; Zhang, Y, 2021) |
| "In total, 279 patients (40 G6PD-deficient and 239 G6PD-normal) with acute ischemic stroke treated with aspirin 100 mg/day from a cohort study were examined." | 4.02 | Association between aspirin-induced hemoglobin decline and outcome after acute ischemic stroke in G6PD-deficient patients. ( Chen, Y; Deng, W; Huang, W; Li, J; Liang, Z; Ou, Z; Ouyang, F; Xing, S; Yu, J; Zeng, J; Zhang, Y, 2021) |
| "Aspirin is an important drug in acute coronary syndromes (ACS) and percutaneous coronary interventions (PCI)." | 3.81 | Antiplatelet and invasive treatment in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency and acute coronary syndrome. The safety of aspirin. ( Kafkas, NV; Liakos, CI; Mouzarou, AG, 2015) |
| "Forty-four patients with Mediterranean-type glucose-6-phosphate dehydrogenase (G-6-PD) deficiency receiving long-term, low-dose aspirin were monitored over three months for evidence of hemolysis." | 3.68 | Long-term, low-dose aspirin is safe in glucose-6-phosphate dehydrogenase deficiency. ( Shalev, O, 1991) |
| "Twenty hemolytic accidents due to G6PD deficiency in Algeria are reported: 13 cases of favism, 2 cases of neonatal jaundice, one drug accident (aspirin), 4 of unknown cause." | 3.65 | [Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency. Aprpos of 20 cases from 1969 to 1974]. ( Benabadji, M; Benamani, M; Benmoussa, M; Kaid, DA; Mérad, F; Messerschmitt, J, 1977) |
| "G6PD deficiency is typically asymptomatic and many CVD patients with this enzyme defect start to take long-term aspirin therapy without G6PD activity examination; however, no consensus on the safety of aspirin in this population has been reached." | 2.72 | Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not? ( Chen, C; Chen, J; Chen, Y; Jiang, Z; Li, J; Li, P; Liang, J; Ou, Z; Ouyang, F; Wei, J; Zeng, J, 2021) |
| "Eleven of these children developed acute renal insufficiency." | 1.28 | Drug-induced haemolysis and renal failure in children with glucose-6-phosphate dehydrogenase deficiency in Afghanistan. ( Choudhry, VP; Fazel, I; Ghafary, A; Ghani, R; Qureshi, MA; Zaher, M, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (71.05) | 18.7374 |
| 1990's | 3 (7.89) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (10.53) | 24.3611 |
| 2020's | 4 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Sanna, GD | 1 |
| Deriu, S | 1 |
| Uras, M | 1 |
| Murgia, A | 1 |
| Talanas, G | 1 |
| Moccia, E | 1 |
| Corda, G | 1 |
| Mura, E | 1 |
| Saba, PS | 1 |
| Parodi, G | 1 |
| Chen, Y | 3 |
| Li, J | 3 |
| Ou, Z | 3 |
| Zhang, Y | 2 |
| Liang, Z | 2 |
| Deng, W | 2 |
| Huang, W | 2 |
| Wu, Z | 1 |
| Jiang, H | 1 |
| Liu, Q | 1 |
| Ouyang, F | 3 |
| Xing, S | 2 |
| Zeng, J | 3 |
| Liang, J | 1 |
| Jiang, Z | 1 |
| Chen, C | 1 |
| Li, P | 1 |
| Chen, J | 1 |
| Wei, J | 1 |
| Yu, J | 1 |
| Feghaly, J | 1 |
| Al Hout, AR | 1 |
| Mercieca Balbi, M | 1 |
| Amekoudi, EY | 1 |
| Sabi, KA | 1 |
| Noto Kadou Kaza, B | 1 |
| Kafkas, NV | 1 |
| Liakos, CI | 1 |
| Mouzarou, AG | 1 |
| Pappas, C | 1 |
| Ntai, K | 1 |
| Parissis, JT | 1 |
| Anastasiou-Nana, M | 1 |
| SZEINBERG, A | 1 |
| KELLERMANN, J | 1 |
| ADAM, A | 1 |
| SHEBA, C | 1 |
| RAMOT, B | 1 |
| PRANKERD, TA | 1 |
| HARLEY, JD | 1 |
| Seeler, RA | 1 |
| Luken, JA | 1 |
| Colonna, P | 1 |
| Pazzi, A | 1 |
| Accardo, G | 1 |
| Aleotti, A | 1 |
| Saletti, G | 1 |
| Ali, NA | 1 |
| al-Naama, LM | 1 |
| Khalid, LO | 1 |
| Kaid, DA | 1 |
| Benmoussa, M | 1 |
| Mérad, F | 1 |
| Benamani, M | 1 |
| Benabadji, M | 1 |
| Messerschmitt, J | 1 |
| Serup, J | 1 |
| Chan, TK | 1 |
| Todd, D | 1 |
| Tso, SC | 1 |
| Glader, BE | 2 |
| Phadke, MA | 1 |
| Kate, SL | 1 |
| Sainami, GS | 1 |
| Mutalik, GS | 1 |
| Phadke, MV | 1 |
| Baxi, AJ | 1 |
| Choudhry, VP | 1 |
| Ghafary, A | 1 |
| Zaher, M | 1 |
| Qureshi, MA | 1 |
| Fazel, I | 1 |
| Ghani, R | 1 |
| Shalev, O | 1 |
| Meloni, T | 1 |
| Forteleoni, G | 1 |
| Ogana, A | 1 |
| Franca, V | 1 |
| Owa, JA | 1 |
| Smirnov, AN | 1 |
| Pochedly, C | 1 |
| Ente, G | 1 |
| Dube, B | 1 |
| Chawla, SC | 1 |
| Vaish, SK | 1 |
| Somani, PN | 1 |
| Srivastava, PK | 1 |
| Onadeko, BO | 1 |
| Bademosi, O | 1 |
| Brown, CB | 1 |
| McMillan, JM | 1 |
| Bateman, CJ | 1 |
| Cattell, WR | 1 |
| Ahmed, I | 1 |
| Olowe, O | 1 |
| Kovalev, IuR | 1 |
| Erman, LV | 1 |
| George, JN | 1 |
| Miller, DR | 1 |
| Weed, RI | 1 |
| Shahidi, NT | 2 |
| Westring, DW | 2 |
| Baumes, RM | 1 |
| Pisciotta, AV | 1 |
3 reviews available for aspirin and Deficiency of Glucose-6-Phosphate Dehydrogenase
| Article | Year |
|---|---|
Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?
Topics: Aspirin; Cardiovascular Diseases; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Hemolysis; | 2021 |
Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aspirin; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Huma | 2017 |
Adverse hematologic effects of drugs.
Topics: Anemia, Hemolytic; Anemia, Macrocytic; Anti-Bacterial Agents; Anticonvulsants; Antidepressive Agents | 1972 |
35 other studies available for aspirin and Deficiency of Glucose-6-Phosphate Dehydrogenase
| Article | Year |
|---|---|
Aspirin adherence in subjects with glucose-6-phosphate-dehydrogenase deficiency having an acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aspirin; Glucose-6-Phosphate; Glucosephosphate Dehydrogenase Deficiency; Hu | 2021 |
Safety and efficacy of low-dose aspirin in ischemic stroke patients with different G6PD conditions.
Topics: Aspirin; Brain Ischemia; Cohort Studies; Drug Therapy, Combination; Glucosephosphate Dehydrogenase; | 2021 |
Association between aspirin-induced hemoglobin decline and outcome after acute ischemic stroke in G6PD-deficient patients.
Topics: Aged; Anemia; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Endpoint Determinati | 2021 |
[Profound anemia, hemoglobinuria ... where to stop in the etiological investigation?].
Topics: Acute Kidney Injury; Adolescent; Anemia, Hemolytic; Aspirin; Blackwater Fever; Erythrocyte Transfusi | 2014 |
Antiplatelet and invasive treatment in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency and acute coronary syndrome. The safety of aspirin.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Aspirin; Drug Therapy, Combination; Drug-Eluting Stents; G | 2015 |
Dual anti-platelet therapy in patients with G6PD deficiency after percutaneous coronary intervention.
Topics: Aged; Aspirin; Drug Therapy, Combination; Glucosephosphate Dehydrogenase Deficiency; Humans; Male; P | 2013 |
Haemolytic jaundice following aspirin administration to a patient with a deficiency of glucose-6-phosphate dehydrogenase in erythrocytes.
Topics: Anemia, Hemolytic; Aspirin; Erythrocytes; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydroge | 1960 |
ENZYMES AND DRUG SENSITIVITY. GLUCOSE 6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
Topics: Acetanilides; Aminopyrine; Aminosalicylic Acid; Aminosalicylic Acids; Anemia, Hemolytic; Antimalaria | 1964 |
GROSS CONGENITAL MALFORMATIONS IN SIBLINGS OF CHILDREN WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT ERYTHROCYTES.
Topics: Abnormalities, Drug-Induced; Aspirin; Congenital Abnormalities; Erythrocytes; Glucosephosphate Dehyd | 1964 |
Hemolysis in ARF in a G6PD-deficient patient: case 2.
Topics: Aspirin; Child; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Male; Rheumatic Fever | 1984 |
Aspirin and glucose-6-phosphate dehydrogenase deficiency.
Topics: Aspirin; Child; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Male | 1981 |
[Scanning electron microscopic study of the morphological changes induced by acetylsalicylic acid in therapeutic doses in the red blood cells of a patient with a very severe G6PD deficiency and clinical manifestations of favism].
Topics: Aspirin; Erythrocytes; Favism; Glucosephosphate Dehydrogenase Deficiency; Humans; In Vitro Technique | 1980 |
Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
Topics: Anti-Bacterial Agents; Antimalarials; Aspirin; Case-Control Studies; Chloramphenicol; Drug Evaluatio | 1999 |
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency. Aprpos of 20 cases from 1969 to 1974].
Topics: Adolescent; Anemia, Hemolytic; Aspirin; Child; Child, Preschool; Favism; Glucosephosphate Dehydrogen | 1977 |
[Erythrocyte glucose-6-phosphate dehydrogenase deficiency. Review and report of a case].
Topics: Adult; Anemia, Hemolytic; Antipyrine; Aspirin; Erythrocytes; Glucosephosphate Dehydrogenase; Glucose | 1977 |
Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency.
Topics: Aspirin; Cell Survival; China; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Male; N | 1976 |
Evaluation of the hemolytic role of aspirin in glucose-6-phosphate dehydrogenase deficiency.
Topics: Aspirin; Bilirubin; Child; Erythrocytes; Female; Gentisates; Glucosephosphate Dehydrogenase Deficien | 1976 |
Hyperhaemolytic and vascular occlusive crises in sickle cell disease. A case report with brief review of literature.
Topics: Anemia, Hemolytic; Anemia, Sickle Cell; Aspirin; Child; Glucosephosphate Dehydrogenase Deficiency; H | 1975 |
Salicylate-induced injury of pyruvate-kinase-deficient erythrocytes.
Topics: Adenosine Triphosphate; Anemia, Hemolytic; Aspirin; Erythrocytes; Glucose; Glucosephosphate Dehydrog | 1976 |
Drug-induced haemolysis and renal failure in children with glucose-6-phosphate dehydrogenase deficiency in Afghanistan.
Topics: Acute Kidney Injury; Adolescent; Afghanistan; Antimalarials; Aspirin; Child; Child, Preschool; Chlor | 1990 |
Long-term, low-dose aspirin is safe in glucose-6-phosphate dehydrogenase deficiency.
Topics: Adult; Aspirin; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Male; Middle Aged; Saf | 1991 |
Aspirin-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase-deficient children with systemic arthritis.
Topics: Anemia, Hemolytic; Arthritis; Aspirin; Child, Preschool; Glucosephosphate Dehydrogenase Deficiency; | 1989 |
Relationship between exposure to icterogenic agents, glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Nigeria.
Topics: Aspirin; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Infant; Infant, Newborn; Jaundic | 1989 |
[Acute drug-induced hemolytic anemia].
Topics: Acute Disease; Adult; Anemia, Hemolytic; Aspirin; Diagnosis, Differential; Female; Glucosephosphate | 1989 |
Consumption coagulopathy following haemolytic crisis in glucose-6-phosphate dehydrogenase deficient subjects.
Topics: Adolescent; Adult; Aspirin; Disseminated Intravascular Coagulation; Glucosephosphate Dehydrogenase D | 1972 |
Glucose-6-phosphate dehydrogenase deficiency and intravascular haemolysis.
Topics: Adolescent; Adult; Anemia, Hemolytic; Aspirin; Dapsone; Female; Glucosephosphate Dehydrogenase Defic | 1974 |
Acute renal failure following analgesic overdose in G6PD deficiency.
Topics: Acute Disease; Acute Kidney Injury; Adult; Anemia, Hemolytic; Anemia, Sideroblastic; Aspirin; Biopsy | 1972 |
Haemoglobinuria in Nigerian children.
Topics: Acetaminophen; Aspirin; Autopsy; Brain; Caffeine; Child; Child, Preschool; Coombs Test; Diagnosis, D | 1971 |
[Genesis of drug-induced hemolytic jaundice].
Topics: Adolescent; Aminopyrine; Anemia, Hemolytic; Aspirin; Child; Female; Glucosephosphate Dehydrogenase; | 1971 |
Heinz body hemolytic anemias.
Topics: Anemia, Hemolytic; Aspirin; Child; Female; Glucosephosphate Dehydrogenase Deficiency; Heinz Bodies; | 1970 |
Acetylsalicylic acid--induced hemolysis and its mechanism.
Topics: Adolescent; Anemia, Hemolytic; Aspirin; Child; Erythrocyte Aging; Erythrocytes; Gentisates; Glucosep | 1970 |
[Blood donors. Importance of systematic detection of GPD (glucosephosphate-6-dehydrogenase) deficiency].
Topics: Ascorbic Acid; Aspirin; Blood Donors; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; | 1970 |
Drug-induced hemolysis: biochemical considerations.
Topics: Acetanilides; Anemia, Hemolytic; Aspirin; Biotransformation; Erythrocytes; Glucosephosphate Dehydrog | 1970 |
Hemolytic anemia complicating viral hepatitis and G-6-PD deficiency.
Topics: Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Aspirin; Glucosephosphate Dehydrogenase Deficiency | 1969 |
Anemia, cataracts, and seizures in patient with glucose-6-phosphate dehydrogenase deficiency.
Topics: Anemia, Hemolytic, Congenital Nonspherocytic; Aspirin; Cataract; Chromium Isotopes; Electrophoresis; | 1966 |